Literature DB >> 20001348

Epidemiological analysis of Streptococcus pyogenes infections in Hong Kong.

Janice C K Chan1, Yiu-Wai Chu, Man-Yu Chu, Terence K M Cheung, Janice Y C Lo.   

Abstract

AIMS: The aim of this study was to characterise clinical and microbiological features of isolates obtained from both invasive and non-invasive Streptococcus pyogenes infections in Hong Kong, between October 2005 and April 2008.
METHOD: Clinical data of invasive isolates were collected retrospectively. Altogether 281 isolates were emm sequence typed and tested for antimicrobial susceptibility using disk diffusion method. Detection of the presence of the streptococcal pyrogenic exotoxin genes was also carried out.
RESULTS: emm1, emm4 and emm12 were the most prevalent in both the invasive and non-invasive groups with an increase in incidence of emm22 compared with a previous study. emm22 was associated with invasive cellulitis and wound infection. The overall rate of erythromycin resistance was 25.6% and was significantly higher in emm22 strains (85.7%). The phage-encoded superantigen gene speA was exclusively associated with emm1 in both invasive and non-invasive isolates.
CONCLUSION: This study revealed a changing epidemiology of S. pyogenes infection in Hong Kong, with a unique pattern compared with other Asian countries. Invasiveness is not related to the presence of speA, speC or ssa genes and the antimicrobial resistance rate was high for macrolides. The findings have an implication on the use and efficacy of the polyvalent S. pyogenes vaccine under development.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20001348     DOI: 10.3109/00313020903257723

Source DB:  PubMed          Journal:  Pathology        ISSN: 0031-3025            Impact factor:   5.306


  9 in total

1.  In vitro activities of retapamulin and 16 other antimicrobial agents against recently obtained Streptococcus pyogenes isolates.

Authors:  Emilio Pérez-Trallero; Esther Tamayo; Milagrosa Montes; José M García-Arenzana; Victor Iriarte
Journal:  Antimicrob Agents Chemother       Date:  2011-02-22       Impact factor: 5.191

Review 2.  Population biology of Gram-positive pathogens: high-risk clones for dissemination of antibiotic resistance.

Authors:  Rob J L Willems; William P Hanage; Debra E Bessen; Edward J Feil
Journal:  FEMS Microbiol Rev       Date:  2011-07-04       Impact factor: 16.408

3.  Epidemiology and molecular characterization of macrolide-resistant Streptococcus pyogenes in Taiwan.

Authors:  Chia-Ying Huang; Jui-Fen Lai; I-Wen Huang; Pei-Chen Chen; Hui-Ying Wang; Yih-Ru Shiau; Ya-Wen Cheng; Li-Yun Hsieh; Shan-Chwen Chang; Tsai-Ling Yang Lauderdale
Journal:  J Clin Microbiol       Date:  2013-12-04       Impact factor: 5.948

Review 4.  Streptococcus pyogenes and re-emergence of scarlet fever as a public health problem.

Authors:  Samson Sy Wong; Kwok-Yung Yuen
Journal:  Emerg Microbes Infect       Date:  2012-07-11       Impact factor: 7.163

5.  Update on the clinical utility and optimal use of cefditoren.

Authors:  José Barberán; Lorenzo Aguilar; María-José Giménez
Journal:  Int J Gen Med       Date:  2012-05-21

Review 6.  Cefditoren in upper and lower community-acquired respiratory tract infections.

Authors:  Francisco Soriano; María-José Giménez; Lorenzo Aguilar
Journal:  Drug Des Devel Ther       Date:  2011-02-09       Impact factor: 4.162

7.  Scarlet fever epidemic, Hong Kong, 2011.

Authors:  Emma Y Y Luk; Janice Y C Lo; Amy Z L Li; Michael C K Lau; Terence K M Cheung; Alice Y M Wong; Monica M H Wong; Christine W Wong; Shuk-kwan Chuang; Thomas Tsang
Journal:  Emerg Infect Dis       Date:  2012-10       Impact factor: 6.883

8.  Genome Analysis of Streptococcus pyogenes Associated with Pharyngitis and Skin Infections.

Authors:  Joe Ibrahim; Jonathan A Eisen; Guillaume Jospin; David A Coil; Georges Khazen; Sima Tokajian
Journal:  PLoS One       Date:  2016-12-15       Impact factor: 3.240

Review 9.  Revisiting cefditoren for the treatment of community-acquired infections caused by human-adapted respiratory pathogens in adults.

Authors:  María-José Giménez; Lorenzo Aguilar; Juan José Granizo
Journal:  Multidiscip Respir Med       Date:  2018-11-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.